Woods; Timothy Andrew

Patent Applications and Registrations

Patent applications and USPTO patent grants for Woods; Timothy Andrew.The latest application filed is for "jak inhibitors".

Company Profile

2.7.13

Woods; Timothy Andrew - Edinburgh IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Jak Inhibitors App 20200339585 - Hu; Jingdan ; et al.	2020-10-29
Pyrazolylaminobenzimidazole derivatives as JAK inhibitors Grant 10,323,019 - Bastian , et al.	2019-06-18
Pyrazolylaminobenzimidazole Derivatives As Jak Inhibitors App 20190177300 - Bastian; Jolie Anne ; et al.	2019-06-13
Pyrazolylaminobenzimidazole Derivatives As Jak Inhibitors App 20180325873 - Bastian; Jolie Anne ; et al.	2018-11-15
Novel Forms of [R-(R,R)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)carbonyl]-1H-P- yrrole-1-Heptanoic Acid Calcium Salt (2:1) App 20180009748 - Krzyzaniak; Joseph Francis ; et al.	2018-01-11
Forms of [R-(R,R)]-2-(4-fluorophenyl)-beta, gamma-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-p- yrrole-1-heptanoic acid calcium salt (2:1) Grant 9,790,177 - Laurence , et al. October 17, 2	2017-10-17
Pyrido[2,3-d]pyrimidin-4-one compounds as tankyrase inhibitors Grant 9,624,218 - Chedid , et al. April 18, 2	2017-04-18
Novel Forms of [R-(R,R)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)carbonyl]-1H-P- yrrole-1-Heptanoic Acid Calcium Salt (2:1) App 20170022156 - Krzyzaniak; Joseph Francis ; et al.	2017-01-26
Selective BACE1 inhibitors Grant 9,522,923 - Richards , et al. December 20, 2	2016-12-20
5'-substituted Nucleoside Compounds App 20160326208 - CORTEZ; Guillermo S ; et al.	2016-11-10
PYRIDO[2,3-d]PYRIMIDIN-4-ONE COMPOUNDS AS TANKYRASE INHIBITORS App 20160251348 - CHEDID; Marcio ; et al.	2016-09-01
Selective Bace1 Inhibitors App 20160244465 - Richards; Simon James ; et al.	2016-08-25
Novel Forms of [R-(R,R)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)carbonyl]-1H-P- yrrole-1-Heptanoic Acid Calcium Salt (2:1) App 20160046575 - Krzyzaniak; Joseph Francis ; et al.	2016-02-18
CDC7 inhibitors Grant 9,156,824 - Dally , et al. October 13, 2	2015-10-13
Novel Forms of [R-(R,R)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)carbonyl]-1H-P- yrrole-1-Heptanoic Acid Calcium Salt (2:1) App 20150045563 - Krzyzaniak; Joseph Francis ; et al.	2015-02-12
CDC7 Inhibitors App 20140275121 - DALLY; Robert Dean ; et al.	2014-09-18
Imidazole derivatives useful for the treatment of arthritis Grant 8,648,200 - Hughes , et al. February 11, 2	2014-02-11
Novel Forms of [R-(R,R)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)carbonyl]-1H-P- yrrole-1-Heptanoic Acid Calcium Salt (2:1) App 20140018546 - Krzyzaniak; Joseph Francis ; et al.	2014-01-16
Novel Imidazole Derivatives Useful for the Treatment of Arthritis App 20120302608 - Hughes; Norman Earle ; et al.	2012-11-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.